 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
NanoString Establishes Dx Unit as Breast Cancer Test Moves Closer to FDA Submission
May 29, 2012
NanoString Establishes Dx Unit as Breast Cancer Test Moves Closer to FDA Submission
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- NanoString Technologies Files to Go Public
May 20, 2013 / GenomeWeb Daily News - NanoString Technologies Hopes to Achieve FDA Clearance for Breast Cancer Test by 2012
December 7, 2010 / BioArray News - NanoString, Broad Institute Strike Pact to Study Molecular Networks
November 18, 2009 / GenomeWeb Daily News - Dx Firms GenMark, Nanosphere, CombiMatrix Attribute Q1 Revenue Growth to Sales Efforts
May 14, 2013 / BioArray News - NanoString Takes Option to Liver Cancer Gene Signature for Possible Assay Development
April 17, 2013 / GenomeWeb Daily News